Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Settles Short-Lived Suit Over Janssen's Psoriasis Drug Promo

Apr 29 2019

• By Brenda Sandburg

PSORIASIS Text, On Background of Medicaments Composition, Stethoscope, mix therapy drugs doctor flu antibiotic pharmacy medicine medical

Related Content

Novartis Can't Halt Janssen's Promo Comparing Their Psoriasis Drugs

Mar 06 2019

J&J's Spravato's Star Power Rises While Zytiga's Sets

Apr 16 2019

AbbVie’s Humira Succession Plan Begins Taking Shape With Skyrizi US Approval

Apr 24 2019

ECLIPSE: J&J's Tremfya Beats Novartis' Cosentyx For Long-Term Psoriasis Clearance

Dec 13 2018

Related Companies

Novartis AG

Johnson & Johnson

AbbVie Inc.

Amgen, Inc.

UCB S.A.

Additional Topics

United States Advertising, Marketing & Sales Legal Issues Commercial Dermatology BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window